Chloroquine and hydroxychloroquine are still available to use by a physician but much better protocols are available. All the clinical trials I personally know of have concluded at this time. Now, based on on all the metadata analysis the benifits are still not not established and it is not the leading choice of therapy.

Whereas treatment with a combination anticoagulants, steriods, and other immune suppressent/antibody cocktail is proving to be much more effective in clinical settings and leading to a higher percentage of favorable outcomes. Compound that with remdisovir, which is in such short supply right now, there are many tools in the toolkit. The medical community is sharing information at a rapid pace and protocols are constantly being adjusted. At this time i see no clinics favoring one treatment over the other due to politics or financial gain.. especially since many of the clinics are now treating their own colleagues. Preventing patients from disseminating introvascular coagulation (DIC) and intubation are keys to favorable outcomes and preventing further multi system failure and post recovery chronic conditions.

Unfortunately, there is a rise in intubations again now, especially in Houston / San Antonio area. Fingers crossed it is curbed.